Publications by authors named "Marc Capet"

Claim this Profile
A
Administration of oxathridine, a first-in-class histamine-3 receptor partial agonist in healthy male volunteers: Central nervous system depression and pseudo-hallucinations.
Francis M Dijkstra, Rob G J A Zuiker, Jules A A C Heuberger, Kawita M S Kanhai, Marieke De Kam, Marc Capet

Br J Clin Pharmacol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring occupancy of the histamine H receptor by pitolisant in humans using PET.
Pablo Rusjan, Pamela Sabioni, Patricia Di Ciano, Esmaeil Mansouri, Isabelle Boileau, Marc Capet

Br J Pharmacol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel pyrrolidinone derivative lacks claimed histamine H receptor stimulation in receptor binding and functional studies.
David Reiner, Aleksandra Zivkovic, Olivier Labeeuw, Stéphane Krief, Marc Capet

Eur J Med Chem· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of nanomolar ligands with novel scaffolds for the histamine H4 receptor by virtual screening.
Nicolas Levoin, Olivier Labeeuw, Xavier Billot, Thierry Calmels, Denis Danvy, Marc Capet

Eur J Med Chem· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of a 2-benzothiazolylphenylmethyl ether class of histamine H4 receptor antagonists.
Olivier Labeeuw, Nicolas Levoin, Xavier Billot, Denis Danvy, Thierry Calmels, Marc Capet

Bioorg Med Chem Lett· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving selectivity of dopamine D3 receptor ligands.
Marc Capet, Thierry Calmels, Nicolas Levoin, Denis Danvy, Isabelle Berrebi-Bertrand

Bioorg Med Chem Lett· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of the binding mode and interacting amino-acids for dibasic H3 receptor antagonists.
Nicolas Levoin, Olivier Labeeuw, Stéphane Krief, Thierry Calmels, Olivia Poupardin-Olivier, Marc Capet

Bioorg Med Chem· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel and highly potent histamine H3 receptor ligands. Part 3: an alcohol function to improve the pharmacokinetic profile.
Olivier Labeeuw, Nicolas Levoin, Olivia Poupardin-Olivier, Thierry Calmels, Xavier Ligneau, Marc Capet

Bioorg Med Chem Lett· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel and highly potent histamine H3 receptor ligands. Part 2: exploring the cyclohexylamine-based series.
Olivier Labeeuw, Nicolas Levoin, Olivia Poupardin-Olivier, Thierry Calmels, Xavier Ligneau, Marc Capet

Bioorg Med Chem Lett· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel and highly potent histamine H3 receptor ligands. Part 1: withdrawing of hERG activity.
Nicolas Levoin, Olivier Labeeuw, Thierry Calmels, Olivia Poupardin-Olivier, Isabelle Berrebi-Bertrand, Marc Capet

Bioorg Med Chem Lett· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homology Model Versus X-ray Structure in Receptor-based Drug Design: A Retrospective Analysis with the Dopamine D3 Receptor.
Nicolas Levoin, Thierry Calmels, Stéphane Krief, Denis Danvy, Isabelle Berrebi-Bertrand, Marc Capet

ACS Med Chem Lett· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histamine and tele-methylhistamine quantification in cerebrospinal fluid from narcoleptic subjects by liquid chromatography tandem mass spectrometry with precolumn derivatization.
Mikaël Croyal, Yves Dauvilliers, Olivier Labeeuw, Marc Capet, Jean-Charles Schwartz

Anal Biochem· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of amides surrogates of dopamine D3 receptor ligands.
Mickaël Jean, Jacques Renault, Nicolas Levoin, Denis Danvy, Thierry Calmels, Marc Capet

Bioorg Med Chem Lett· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A solid phase parallel synthesis of diverse amides as dopamine D3 receptor ligands.
Mickaël Jean, Jacques Renault, Jean-Claude Camelin, Nicolas Levoin, Denis Danvy, Marc Capet

J Enzyme Inhib Med Chem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refined docking as a valuable tool for lead optimization: application to histamine H3 receptor antagonists.
Nicolas Levoin, Thierry Calmels, Olivia Poupardin-Olivier, Olivier Labeeuw, Denis Danvy, Marc Capet

Arch Pharm (Weinheim)· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected formation of aryl ketones by palladium-catalyzed coupling of aryl bromides with vinylic acetates.
Mickaël Jean, Jacques Renault, Philippe Uriac, Marc Capet, Pierre van de Weghe

Org Lett· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parallel synthesis and dopamine D3/D2 receptor screening of novel {4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}carboxamides.
Philipp Heidler, Vida Zohrabi-Kalantari, Thierry Calmels, Marc Capet, Isabelle Berrebi-Bertrand

Bioorg Med Chem· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis